Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis

Fig. 8

Forest plot showing the impact of SCT therapy on BCVA at month 12. The risk ratio in the fixed-effects model between post-operative and preoperative groups in BCVA after 12 months was 11.00 (95% confidence interval: 2.36–51.36, P = 0.002). Heterogeneity was low (I2 = 0%)

Back to article page